Markers of coagulation and inflammation and adverse events in patients with active cancer and atherosclerosis: common features and differences
Introduction. Thrombotic complications (TC) in different vascular systems dictate the fate of high-risk patients. In cardiological practice, patients with advanced atherosclerotic vascular disease (MFA) represent the most vulnerable group. Malignant neoplasm (MN) is one of the most significant risk...
Main Authors: | Yu. A. Fedotkina, A. L. Komarov, А. В. Dobrovolsky, E. N. Krivosheeva, О. О. Frolkova, E. V. Titaeva, T. V. Balakhonova, Е. Р. Panchenko |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«REMEDIUM GROUP» Ltd.
2023-01-01
|
Series: | Атеротромбоз |
Subjects: | |
Online Access: | https://www.aterotromboz.ru/jour/article/view/287 |
Similar Items
-
ХАРАКТЕР ИЗМЕНЕНИЙ ГЕМОСТАЗИОЛОГИЧЕСКИХ ПОКАЗАТЕЛЕЙ У БЕРЕМЕННЫХ С БЕССИМПТОМНЫМ И ЛЕГКИМ ТЕЧЕНИЕМ COVID-19
by: Т. Н. Гриневич, et al.
Published: (2024-01-01) -
Management of ischemic risk events in patients with multifocal atherosclerosis and type 2 diabetes mellitus
by: O. L. Barbarash, et al.
Published: (2020-06-01) -
PREVALENCE OF MULTI-FOCAL ATHEROSCLEROTIC PATHOLOGY ACROSS AGE GROUPS
by: A. N. Sumin, et al.
Published: (2013-04-01) -
Diagnosis of multifocal atherosclerosis in low-to moderate-risk patients and their restratification
by: O. V. Fatenkov, et al.
Published: (2020-11-01) -
Prognostic significance of atherosclerosis of one or two vascular systems in patients with high and very high cardiovascular risk
by: V. V. Genkel, et al.
Published: (2021-03-01)